LVTTF News and Press, Levitee Labs From 11/15/21

Levitee adds Noha ElSayed, an expert in compounding and pharmacy operations, to the Levitee Clinics and Levitee Pharmacies management team Mrs. ElSayed has over 20 years of experience as a pharmacist with specialization in addiction medicine, ketamine compounding, and hepatitis C tr...

Signed LOI to acquire 100% interest in chain of specialty addiction pharmacies in Vancouver, BC Acquisition price of $4.0 million based upon approximately 4.7x trailing 6 months annualized EBITDA of $850,000 The chain operates 3 locations, which will be added to the Levitee Pharma...

Levitee Labs achieves combined September 2021 and October 2021 revenues of $1,553,728 Consistent revenue growth and acquisitions across core divisions of the company, including Levitee Clinics, Levitee Pharmacies, and Earth Circle Organics VANCOUVER, British Columbi...

Levitee Labs acquiring 51% interest in new R&D compounding pharmacy in Calgary, Alberta, Canada New pharmacy to focus on production of intranasal ketamine and sublingual preparations, topical and transdermal formulations, capsules and other Levitee-branded compounds and products ...

Levitee Labs will be a Gold Sponsor and VIP Lounge Sponsor at the world’s largest psychedelic medicine conference If you would like to attend either of Levitee’s private events, you can register at this link and Levitee Labs’ team will share more details: ...

Levitee Labs has acquired its first five addiction clinics, three specialized pharmacies and pioneering technology company that cumulatively treat tens of thousands of Canadian patients with substance use disorder, addiction, and chronic pain Levitee Labs has recently signed an LOI ...

VANCOUVER, British Columbia, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Levitee Labs Inc. (CSE: LVT) (OTCMKTS: LVTTF) (FSE: 7H7) (the " Company " or " Levitee ”), an integrative wellness company with a diversified portfolio of healthcare and wellness assets, i...

VANCOUVER, British Columbia, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Levitee Labs Inc. (the " Company " or " Levitee Labs ”) (CSE: LVT) (OTC: LVTTF) (FSE: 7H7) an integrative wellness company with a diversified portfolio of healthcare and wellness assets, is pleased t...

Dr. Mosli has over a decade of healthcare experience specializing in addiction, leading innovation in reorienting health systems, and increasing health equality Dr. Mosli spent the last five years as a Medical Officer of Canada’s largest province-wide, fully-integrated health...

Signed LOI to acquire a compounding pharmacy in Calgary, Alberta, Canada Valuation of approximately 3.5x TTM EBITDA of $180,000 Levitee Labs to use compounding capabilities to build its own drug brands VANCOUVER, British Columbia, Oct. 12, 2021 (...